Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neurol Ther ; 10(1): 391-400, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33738711

ABSTRACT

INTRODUCTION: Patients with Parkinson's disease (PD) present a variety of oral disease that can be worsened by xerostomia and sialorrhea. The patients' physical limitations, for example rigidity and tremor, add to the difficulty of oral care by the general dental surgeon. The objective of the present review was to organize a list of evidence-based recommendations for the oral care of patients with PD. METHODS: A systematic review of the literature was carried out by specialists who selected the relevant papers and created a list of recommendations based upon the literature. RESULTS: Fourteen papers (data reported in 16 articles) were included in this review. Patients with PD had reduced quality of oral health and hygiene, and high prevalence of gingival recession, periodontal disease, dental calculus, tooth decay, tooth mobility and loss, drooling, xerostomia, dysphagia and temporomandibular disorders. Most studies offered class IV evidence, while one paper had class II evidence. CONCLUSION: Patients with PD present poor oral health with conditions that are mostly preventable.

2.
J Oral Pathol Med ; 43(7): 545-53, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24484176

ABSTRACT

BACKGROUND: Calcifying cyst odontogenic tumour (CCOT) is a rare benign cystic neoplasm of odontogenic origin. MMPs are responsible for extracellular matrix remodelling and, together their inhibitors and inducer, determinate the level of its turnover in pathological processes, leading to an auspicious microenvironment for tumour development. Thus, our goal was to evaluate matrix metalloproteinases (MMPs-2, -7, -9 and -14), their inhibitors (TIMPs-2, -3, -4 and RECK) and its inductor (EMMPRIN) expression in CCOT. MATERIALS AND METHODS: We used 18 cases of CCOT submitted to immunolocalization of the target proteins and analysed in both neoplastic odontogenic epithelial and stromal compartments. RESULTS: All molecules evaluated were expressed in both compartments in CCOT. In epithelial layer, immunostaining for MMPs, TIMPs, RECK and EMMPRIN was found in basal, suprabasal spindle and stellate cells surrounding ghost cells and ghost cells themselves, except for MMP-9 and TIMP-2 which were only expressed by ghost cells. In stromal compartment, extracellular matrix, mesenchymal (MC) and endothelial cells (EC) were positive for MMP-2, -7, TIMP-3 and -4, while MMP-9, TIMP-2 and RECK were positive only in MC and MMP-14 only in EC. Statistical significance difference was found between both compartments for MMP-9 (P < 0.001), RECK (P = 0.004) and EMMPRIN (P < 0.001), being more expressed in epithelium than in stroma. Positive correlation between both stromal EMMPRIN and RECK expression was found (R = 0.661, P = 0.003). CONCLUSIONS: We concluded that these proteins/enzymes are differentially expressed in both epithelium and stroma of CCOT, suggesting an imbalance between MMPs and their inducer/inhibitors may contribute on the tumour behaviour.


Subject(s)
Basigin/analysis , GPI-Linked Proteins/analysis , Matrix Metalloproteinases/analysis , Odontogenic Tumors/chemistry , Tissue Inhibitor of Metalloproteinases/analysis , Adolescent , Adult , Endothelial Cells/chemistry , Endothelial Cells/enzymology , Epithelium/chemistry , Epithelium/enzymology , Extracellular Matrix/chemistry , Extracellular Matrix/enzymology , Female , Humans , Male , Matrix Metalloproteinase 14/analysis , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 7/analysis , Matrix Metalloproteinase 9/analysis , Mesoderm/chemistry , Mesoderm/enzymology , Middle Aged , Neoplasm Proteins/analysis , Odontogenic Tumors/enzymology , Tissue Inhibitor of Metalloproteinase-2/analysis , Tissue Inhibitor of Metalloproteinase-3/analysis , Tumor Microenvironment , Young Adult , Tissue Inhibitor of Metalloproteinase-4
3.
Behav Pharmacol ; 23(7): 703-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22914075

ABSTRACT

This study investigated whether perinatal exposure to picrotoxin, a GABAA antagonist, modifies the effect of muscimol, a GABAA agonist, on the sexual behavior of adult male rats. Two hours after birth and then once daily during the next 9 days of lactation, dams received picrotoxin (0.75 mg/kg subcutaneously) or saline (1 ml/kg subcutaneously). The adult male offspring from the picrotoxin and saline groups received saline (1 ml/kg intraperitoneally) or muscimol (1 mg/kg intraperitoneally), and 15 min later, their sexual behavior was assessed. Muscimol treatment in the saline-exposed group increased the mount and intromission latencies. However, these effects were absent in the picrotoxin-exposed groups. The latencies to first ejaculation, postejaculatory mount, and intromission were decreased in both picrotoxin-exposed groups relative to the saline-exposed groups. The picrotoxin+muscimol-treated rats required more intromissions to ejaculate and the picrotoxin-exposed groups made more ejaculations than the saline-exposed groups. Thus, muscimol treatment did not increase the mount and intromission latencies following picrotoxin exposure, but increased the ejaculation frequency, which did not differ between the picrotoxin+muscimol and the picrotoxin+saline groups. These data indicate that perinatal picrotoxin treatment interfered with GABAA receptor development.


Subject(s)
GABA Antagonists/pharmacology , Muscimol/pharmacology , Picrotoxin/pharmacology , Sexual Behavior, Animal/drug effects , Animals , Female , GABA Antagonists/administration & dosage , GABA-A Receptor Agonists/administration & dosage , GABA-A Receptor Agonists/pharmacology , Injections, Subcutaneous , Lactation , Male , Muscimol/administration & dosage , Picrotoxin/administration & dosage , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Wistar , Receptors, GABA-A/drug effects , Receptors, GABA-A/metabolism
4.
Eur J Oral Sci ; 117(6): 676-84, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20121930

ABSTRACT

Mandibular movements occur through the triggering of trigeminal motoneurons. Aberrant movements by orofacial muscles are characteristic of orofacial motor disorders, such as nocturnal bruxism (clenching or grinding of the dentition during sleep). Previous studies have suggested that autonomic changes occur during bruxism episodes. Although it is known that emotional responses increase jaw movement, the brain pathways linking forebrain limbic nuclei and the trigeminal motor nucleus remain unclear. Here we show that neurons in the lateral hypothalamic area, in the central nucleus of the amygdala, and in the parasubthalamic nucleus, project to the trigeminal motor nucleus or to reticular regions around the motor nucleus (Regio h) and in the mesencephalic trigeminal nucleus. We observed orexin co-expression in neurons projecting from the lateral hypothalamic area to the trigeminal motor nucleus. In the central nucleus of the amygdala, neurons projecting to the trigeminal motor nucleus are innervated by corticotrophin-releasing factor immunoreactive fibers. We also observed that the mesencephalic trigeminal nucleus receives dense innervation from orexin and corticotrophin-releasing factor immunoreactive fibers. Therefore, forebrain nuclei related to autonomic control and stress responses might influence the activity of trigeminal motor neurons and consequently play a role in the physiopathology of nocturnal bruxism.


Subject(s)
Brain Stem/physiology , Mandible/physiology , Prosencephalon/physiology , Amygdala/anatomy & histology , Amygdala/physiology , Animals , Brain Stem/anatomy & histology , Coloring Agents , Corticotropin-Releasing Hormone/analysis , Fluorescent Antibody Technique , Hypothalamic Area, Lateral/physiology , Intracellular Signaling Peptides and Proteins/analysis , Limbic System/physiology , Male , Motor Neurons/cytology , Motor Neurons/physiology , Movement , Nerve Fibers/physiology , Nerve Fibers/ultrastructure , Neural Pathways/anatomy & histology , Neural Pathways/physiology , Neurons, Efferent/physiology , Neurons, Efferent/ultrastructure , Neuropeptides/analysis , Orexins , Prosencephalon/anatomy & histology , Rats , Rats, Wistar , Reticular Formation/anatomy & histology , Reticular Formation/physiology , Stereotaxic Techniques , Subthalamic Nucleus/anatomy & histology , Subthalamic Nucleus/physiology , Trigeminal Nuclei/anatomy & histology , Trigeminal Nuclei/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...